Exendin agonist compounds
US7223725B1 · kind B1 · utility
52Cited by
12References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 13, 1998 |
| Grant date | May 29, 2007 |
| Priority date | — |
| Expiry date | Nov 13, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01K2267/0362
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel exendin agonist compounds useful in treatment of Type I and II diabetes, and useful in lowering plasma glucose levels, reducing body weight, and delaying and/or slowing gastric emptying.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.